Development Partners

BioMotiv, the for-profit accelerator of The Harrington Project, is the lead funder of TamRx. BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, mission-driven model that efficiently aligns capital and collaborations for the benefit of inventors and investors, and ultimately physicians and patients.